Salim Yazji serves as Executive at Oncternal Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Salim Yazji has executed 9 insider transactions totaling $24.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 3, 2024 involved selling 19,742 shares valued at $9.9K.
Salim Yazji currently holds 128,635 shares of Oncternal Therapeutics, Inc. (ONCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Salim Yazji has been a net buyer of ONCT stock. They have purchased $24.2K and sold $0 worth of shares.
Salim Yazji's most recent insider trade was on Jan 3, 2024, when they sold 19,742 shares at $0.50 per share.
Get notified when new Form 4 filings are submitted
| $0.36 |
| Discretionary |
| Apr 14, 2023 | ONCT | $1.5K | Purchase | 5,000 | $0.30 | Discretionary |
| Apr 13, 2023 | ONCT | $2.9K | Purchase | 10,000 | $0.29 | Discretionary |
| Apr 12, 2023 | ONCT | $2.9K | Purchase | 10,000 | $0.29 | Discretionary |
| Jan 3, 2023 | ONCT | $10.2K | Payment | 9,961 | $1.02 | Discretionary |
| Jul 28, 2022 | ONCT | $0 | Award | 82,500 | $N/A | Discretionary |
| Jan 27, 2022 | ONCT | $16.9K | Purchase | 10,000 | $1.69 | Discretionary |
| Jan 3, 2022 | ONCT | $0 | Award | 57,137 | $N/A | Discretionary |